Nivolumab PD-1 Blockade as Bridge to Allogeneic Stem Cell Transplant (HSCT) in Gray-Zone Lymphoma: Case Report
Maura Nicolosi(Palmetto Hematology Oncology), Barbara Botto, Roberto Freilone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Alessandro Busca(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Mattia Novo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Chiara Maria Dellacasa(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 0
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
|New England Journal of Medicine|2014|301
A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
|British Journal of Haematology|2010|242
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
|Clinical Microbiology and Infection|2014|241